Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis
Advertisement
-- Five PLEDGE studies now active and enrolling patients to evaluate the safety and efficacy of relamorelin (investigational drug) in people with diabetic gastroparesis --